Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis

Abstract Background Tuberculosis (T.B) is one of the major infectious diseases in the developing countries. The diagnosis of extrapulmonary T.B (EPTB) remains problematic and emergence of resistant strains poses a significant threat. Improved diagnosis of tuberculosis is a global priority for proper...

Full description

Bibliographic Details
Main Authors: Asmaa Mohammed Elbrolosy, Rana H. El Helbawy, Osama M. Mansour, Reda Abdel Latif
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Microbiology
Subjects:
Online Access:https://doi.org/10.1186/s12866-021-02210-5
_version_ 1818915693559545856
author Asmaa Mohammed Elbrolosy
Rana H. El Helbawy
Osama M. Mansour
Reda Abdel Latif
author_facet Asmaa Mohammed Elbrolosy
Rana H. El Helbawy
Osama M. Mansour
Reda Abdel Latif
author_sort Asmaa Mohammed Elbrolosy
collection DOAJ
description Abstract Background Tuberculosis (T.B) is one of the major infectious diseases in the developing countries. The diagnosis of extrapulmonary T.B (EPTB) remains problematic and emergence of resistant strains poses a significant threat. Improved diagnosis of tuberculosis is a global priority for proper control. The study aimed to assess the diagnostic accuracy of GeneXpert MTB/RIF assay for diagnosis of pulmonary TB (PTB) and EPTB and to evaluate the performance of GeneXpert system for demonstrating rifampicin resistance among the studied patients. Methods A total of 582 clinical samples (449 pulmonary; 430 sputum and 19 bronchoalveolar lavage (BAL) and 133 extra-pulmonary origins; 26 pleural fluid, 62 CSF, 19 ascetic fluid, 12 pus and 14 urine) were collected from patients under clinical and radiological assessment of either PTB or EPTB who were admitted to Menoufia Chest Hospital over a period of three years. Clinical samples were processed and investigated for detection of Mycobacterium tuberculosis (MTB) by both Xpert assay and the conventional methods including Ziehl-Neelsen (ZN)/acid-fast bacillus (AFB) smear microscopy and Lowenstein-Jensen (LJ) culture. Patients′ demographic, clinical characteristics and risk factors for acquiring rifampicin resistance were analyzed. Results The sensitivity, specificity, false- negative rate and total accuracy of AFB smear microscopy respectively were 72.1 %, 81.3 %, 27.9 and 78.8 % for PTB. However for EPTB, they were 63.2 %, 70.5 %, 36.8 and 68.4 % respectively in relation to LJ culture as the gold standard. GeneXpert MTB/RIF revealed better performance for PTB than EPTB. For PTB, it showed 90.2 % sensitivity, 86.9 % specificity, and 9.8 % false- negative rate. For EPTB, the assay showed a sensitivity of 81.6 %, specificity of 78.9 % and false- negative rate of 18.5 %. Multivariate regression analysis showed that presence of EPTB and contacts with known TB cases were independent risk factors for developing rifampicin resistance. Conclusions GeneXpert MTB/RIF assay is a rapid and highly sensitive technique for diagnosis of PTB or EPTB. Its simplicity and accuracy make this new method a very impressive tool for diagnosis of MTB and rifampicin resistance.
first_indexed 2024-12-20T00:06:20Z
format Article
id doaj.art-3a6cc9f4fd234fa6b7967a70c1df519f
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-12-20T00:06:20Z
publishDate 2021-05-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-3a6cc9f4fd234fa6b7967a70c1df519f2022-12-21T20:00:38ZengBMCBMC Microbiology1471-21802021-05-0121111010.1186/s12866-021-02210-5Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosisAsmaa Mohammed Elbrolosy0Rana H. El Helbawy1Osama M. Mansour2Reda Abdel Latif3Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia UniversityChest Department, Faculty of Medicine, Menoufia UniversityChest Hospital, Ministry of Health and PopulationPublic Health Department, Faculty of Medicine, Menoufia UniversityAbstract Background Tuberculosis (T.B) is one of the major infectious diseases in the developing countries. The diagnosis of extrapulmonary T.B (EPTB) remains problematic and emergence of resistant strains poses a significant threat. Improved diagnosis of tuberculosis is a global priority for proper control. The study aimed to assess the diagnostic accuracy of GeneXpert MTB/RIF assay for diagnosis of pulmonary TB (PTB) and EPTB and to evaluate the performance of GeneXpert system for demonstrating rifampicin resistance among the studied patients. Methods A total of 582 clinical samples (449 pulmonary; 430 sputum and 19 bronchoalveolar lavage (BAL) and 133 extra-pulmonary origins; 26 pleural fluid, 62 CSF, 19 ascetic fluid, 12 pus and 14 urine) were collected from patients under clinical and radiological assessment of either PTB or EPTB who were admitted to Menoufia Chest Hospital over a period of three years. Clinical samples were processed and investigated for detection of Mycobacterium tuberculosis (MTB) by both Xpert assay and the conventional methods including Ziehl-Neelsen (ZN)/acid-fast bacillus (AFB) smear microscopy and Lowenstein-Jensen (LJ) culture. Patients′ demographic, clinical characteristics and risk factors for acquiring rifampicin resistance were analyzed. Results The sensitivity, specificity, false- negative rate and total accuracy of AFB smear microscopy respectively were 72.1 %, 81.3 %, 27.9 and 78.8 % for PTB. However for EPTB, they were 63.2 %, 70.5 %, 36.8 and 68.4 % respectively in relation to LJ culture as the gold standard. GeneXpert MTB/RIF revealed better performance for PTB than EPTB. For PTB, it showed 90.2 % sensitivity, 86.9 % specificity, and 9.8 % false- negative rate. For EPTB, the assay showed a sensitivity of 81.6 %, specificity of 78.9 % and false- negative rate of 18.5 %. Multivariate regression analysis showed that presence of EPTB and contacts with known TB cases were independent risk factors for developing rifampicin resistance. Conclusions GeneXpert MTB/RIF assay is a rapid and highly sensitive technique for diagnosis of PTB or EPTB. Its simplicity and accuracy make this new method a very impressive tool for diagnosis of MTB and rifampicin resistance.https://doi.org/10.1186/s12866-021-02210-5Mycobacterium tuberculosisGeneXpert MTB/RIF assayRifampicin
spellingShingle Asmaa Mohammed Elbrolosy
Rana H. El Helbawy
Osama M. Mansour
Reda Abdel Latif
Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
BMC Microbiology
Mycobacterium tuberculosis
GeneXpert MTB/RIF assay
Rifampicin
title Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
title_full Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
title_fullStr Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
title_full_unstemmed Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
title_short Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
title_sort diagnostic utility of genexpert mtb rif assay versus conventional methods for diagnosis of pulmonary and extra pulmonary tuberculosis
topic Mycobacterium tuberculosis
GeneXpert MTB/RIF assay
Rifampicin
url https://doi.org/10.1186/s12866-021-02210-5
work_keys_str_mv AT asmaamohammedelbrolosy diagnosticutilityofgenexpertmtbrifassayversusconventionalmethodsfordiagnosisofpulmonaryandextrapulmonarytuberculosis
AT ranahelhelbawy diagnosticutilityofgenexpertmtbrifassayversusconventionalmethodsfordiagnosisofpulmonaryandextrapulmonarytuberculosis
AT osamammansour diagnosticutilityofgenexpertmtbrifassayversusconventionalmethodsfordiagnosisofpulmonaryandextrapulmonarytuberculosis
AT redaabdellatif diagnosticutilityofgenexpertmtbrifassayversusconventionalmethodsfordiagnosisofpulmonaryandextrapulmonarytuberculosis